secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001104659-23-026247
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharmaceuticals prices $7.0M public offering of ADSs and warrants; amends prior warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$7.0M from offering of 4.95M ADSs at $1.00/ADS and pre-funded warrants for 2.05M ADSs at $0.9999, each with common warrants.
- Existing warrants from Aug 2022 amended: exercise price reduced from $5.00 to $1.10 per ADS, term extended to Feb 24, 2028.
- Offering closed Feb 24, 2023; net proceeds for general corporate purposes.
- Placement agents: A.G.P./Alliance Global Partners (lead), Maxim Group, Aegis Capital; fees 7% cash plus 1% expense allowance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923026247/0001104659-23-026247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923026247/tm237968d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-026247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer